Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects

Status:
Approved for marketing

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Follow-on study to continue evaluation of the safety of OXC XR as adjunctive therapy in pediatric epilepsy

Supernus Pharmaceuticals, Inc.

Carbamazepine
Oxcarbazepine